XML 25 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statement Of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating revenues      
Total operating revenues $ 3,770 $ 3,906 $ 4,169
Operating expenses      
Selling, general and administrative 1,330 1,368 1,408
Depreciation, amortization and accretion 665 656 700
Loss on impairment of licenses 136 0 3
(Gain) loss on asset disposals, net 18 17 19
(Gain) loss on sale of business and other exit costs, net 0 0 (1)
(Gain) loss on license sales and exchanges, net 3 (2) 0
Total operating expenses 3,782 3,767 4,100
Operating income (loss) (12) 139 69
Investment and other income (expense)      
Equity in earnings of unconsolidated entities 161 158 158
Interest and dividend income 12 10 8
Interest expense (183) (196) (163)
Total investment and other income (expense) (10) (28) 3
Income (loss) before income taxes (22) 111 72
Income tax expense 10 53 37
Net income (loss) (32) 58 35
Less: Net income attributable to noncontrolling interests, net of tax 7 4 5
Net income (loss) attributable to UScellular shareholders $ (39) $ 54 $ 30
Basic weighted average shares outstanding (in shares) 86 85 85
Basic earnings (loss) per share attributable to UScellular shareholders $ (0.46) $ 0.64 $ 0.35
Diluted weighted average shares outstanding (in shares) 86 87 86
Diluted earnings (loss) per share attributable to UScellular shareholders $ (0.46) $ 0.63 $ 0.35
Service      
Operating revenues      
Total operating revenues $ 2,987 $ 3,044 $ 3,125
Operating expenses      
Cost of goods and services sold 724 740 755
Equipment sales      
Operating revenues      
Total operating revenues 783 862 1,044
Operating expenses      
Cost of goods and services sold $ 906 $ 988 $ 1,216